Mohammad AskarPublic working copy · medical review pending

Optic neuropathies · 056

Optic neuropathy: recognise the time-critical pattern

Combine the history with acuity, colour, pupils, disc appearance and visual fields.

Public working copy · medical review pending. Source, translation and medical checks remain open. Read the limitations in the text and references. These educational materials do not replace individual medical assessment. Published: 2026-11-18T19:45:52+01:00. Internal project references lead to this notice. They are not publicly accessible primary sources; the source limitations remain stated in the text.

Localise the deficit, distinguish true swelling from mimics and treat dangerous causes promptly.

Terminology and draft status

Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.

01History and function

Ask where, when and with what: monocular or binocular, sudden or progressive, headache, transient obscurations, facial numbness or diplopia. Young women aged 20–40 more often have inflammatory disease and patients >60 vascular disease, but age and sex do not determine diagnosis. Consider vascular, inflammatory, infectious, compressive, toxic and hereditary causes. 1

Assess acuity, colour vision and red desaturation, pupils, disc appearance and fields. Ishihara plates and apps are not interchangeable without validation. RAPD supports asymmetric afferent disease; its absence does not require exactly symmetric damage or exclude mild disease. Acute retrobulbar neuritis can have a normal disc; later pallor suggests axonal loss rather than a specific cause. Combine fundus examination and OCT with Humphrey perimetry or a documented coarse confrontation field. 1

02True swelling or pseudopapilloedema

Drusen or a small crowded hyperopic disc can mimic swelling, but confirmed pseudopapilloedema does not automatically end investigation when red flags remain. Drusen may cause field loss and coexist with raised intracranial pressure or glaucoma. Vessel trifurcation resembling a Mercedes star is a clue, not proof. 1 2

The original 17-year-old asymptomatic case with normal acuity and colour illustrates this distinction, without independently verified clinical records. FAF can miss buried drusen and B-scan may miss poorly calcified deposits; EDI-OCT helps. CT can show calcification but is not routine first-line imaging in children because of radiation. The separate child with 6/24 and 6/60 acuity and +11.5 D and +13 D refraction illustrates high hyperopia, not a diagnosis established by refraction alone. 1 2

Spontaneous venous pulsation lowers suspicion but cannot absolutely exclude raised intracranial pressure. The original absence in up to 20% of normal people is a teaching estimate without a separately appraised population here; absence alone is not diagnostic. Frisén grades describe swelling severity, not cause, with mild grades especially difficult to distinguish from anomalous discs. Grade 0 denotes no swelling; the retained table lists the original grades 1–5 with corrected vessel-obscuration descriptions. 1 3 4

True swelling or pseudopapilloedema
Frisén gradeClinical description and correction
1C-shaped halo with temporal gap; early margin change
2Circumferential halo and elevation without major vessel obscuration
3Obscuration of a major vessel segment leaving the disc
4Complete obscuration of a major vessel segment on the disc with whole-head elevation; not simply several blocked vessels
5Severe dome-shaped elevation with extensive vessel obscuration; haemorrhage is not required

03Papilloedema and the pressure pathway

Papilloedema means disc swelling from raised intracranial pressure, usually bilateral but sometimes asymmetric or unilateral. Bilateral swelling is not automatically papilloedema. Consider mass, haemorrhage or haematoma, excess CSF production such as plexus papilloma, impaired drainage from congenital disease, tumour or infection, and cerebral venous sinus thrombosis. Measure blood pressure: malignant hypertension is also a cause of disc oedema, not necessarily evidence of raised intracranial pressure. 1 4 11

In the original 35-year-old woman, ask about positional headache, pulsatile tinnitus, transient visual obscurations and sixth-nerve diplopia, drugs including steroid withdrawal, vitamin A derivatives, tetracyclines and lithium, and weight gain, BMI and sleep apnoea. Urgent brain MRI and venography, or CT/CTV when needed, precede lumbar puncture after contraindications are assessed. Admission depends on urgency and available care rather than every patient automatically requiring admission. 1 4 11

Measure opening pressure with correct technique and examine CSF composition. The adult >25 cm H2O threshold must be interpreted in context, not alone or automatically applied to children. Idiopathic intracranial hypertension (IIH) is a diagnosis of exclusion, common in overweight women of reproductive age but not confined to them. LP may transiently lower pressure but serial punctures are not durable routine treatment; urgent vision-threatening disease may need a different escalation pathway. 1 4 11

04Protect vision in IIH

Weight management modifies typical IIH, but the original 5–10% weight-loss example does not guarantee remission. Acetazolamide plus diet gave modest field benefit in the 165-participant IIHTT with mild visual loss; this is not evidence for all severe cases. Topiramate may be selected for associated headache and weight effects with more limited IIH evidence and individual safety review. 1 4 5 11

Monitor acuity, pupils, colour, formal fields and serial fundus/OCT findings. GCL thinning may indicate neuronal loss, but cannot be promised to precede every field defect; segmentation and swelling-related RNFL changes complicate interpretation. Worsening function requires faster reassessment and coordinated ophthalmic, neurological and neurosurgical care. 1 4 5 11

05Arteritic or nonarteritic ischaemia

In a patient >50 with sudden painless visual loss, pale disc swelling or RAPD, seek giant cell arteritis (GCA): temporal headache, scalp tenderness, jaw claudication, weight loss, night sweats, polymyalgia and amaurosis fugax. Start urgent high-dose systemic glucocorticoids on strong suspicion without waiting for blood tests or biopsy. The original IV methylprednisolone 1 g daily for 3 days is a vision-threat protocol example, not a universal regimen for every presentation. 1 6

ESR/CRP support assessment but can be normal. EULAR 2023 recommends temporal and axillary ultrasound first when expertise and rapid access are available; biopsy remains useful in appropriate settings and must not delay treatment. The original second-eye risks 90% untreated versus 10% treated lack an identified population and timing source here and are not universal probabilities. GCA also threatens systemic vessels, including aortic aneurysm and cardiovascular complications, requiring longitudinal rheumatological care. 1 6

NAION associates with hypertension, diabetes, sleep apnoea and a small disc at risk. Normal inflammatory markers and absent systemic symptoms do not alone exclude GCA. No established acute therapy reliably reverses NAION loss; randomised steroid evidence does not support routine treatment. Aspirin may be indicated for vascular risk but is not proven to prevent fellow-eye NAION. Coordinate risk management and visual rehabilitation. 1 7 8

06Typical and atypical neuritis

Typical optic neuritis is often unilateral and subacute at age 20–50, with movement pain, red desaturation and recovery over weeks; none is obligatory and RAPD can be absent. Profound or bilateral loss, absent pain or unusual age requires a broader differential. Brain and orbital MRI assesses nerve inflammation and demyelination; targeted AQP4 and MOG antibodies help identify NMOSD or MOG-associated disease, alongside infectious and systemic assessment. 1 9 10

ONTT found faster recovery with IV methylprednisolone 1 g daily for 3 days followed by oral treatment, without an important durable acuity advantage in typical trial cases. Its harmful recurrence signal concerned oral prednisone alone at 1 mg/kg, not all oral corticosteroid therapy. A later small randomised trial found no significant recovery difference between bioequivalent high-dose oral and IV regimens. These findings do not replace urgent cause-specific treatment or escalation for AQP4/MOG disease; maintain neurological collaboration and serial functional follow-up. 1 9 10

What are the main learning points?

Localise the deficit, distinguish true swelling from mimics and treat dangerous causes promptly.

When is assessment urgent?

Sudden visual loss, suspected giant cell arteritis, papilloedema or new neurological symptoms requires urgent assessment.

References and access status

  1. 1
    Immutable original export; Dr Haya Razzouk attribution

    Complete export read; original attribution and any recording/transcript or appointment not independently verified.

  2. 2
    ODDS Consortium 2018: OCT diagnosis recommendations

    Selected indexed official source sections read on 2026-11-09; direct full text blocked or not read; no supplement appraisal claimed.

  3. 3
    Frisén 1982: staging scheme

    Abstract read; full-text BioC retrieval returned 429. Grade descriptions checked against the AAO figure caption below, not inferred from abstract sensitivity.

  4. 4
    AAO: IIH and Frisén scale figure

    Selected indexed official source sections read on 2026-11-09; direct full text blocked or not read; no supplement appraisal claimed.

  5. 5
    IIHTT 2014 acetazolamide trial

    Selected complete methods and abstract conclusion indexed text read: mild visual loss, 165 participants, modest field benefit. Full report unread.

  6. 6
    EULAR 2023 imaging recommendations

    Selected indexed official source sections read on 2026-11-09; direct full text blocked or not read; no supplement appraisal claimed.

  7. 7
    Saxena et al 2018: NAION steroid randomised trial

    Selected indexed official source sections read on 2026-11-09; direct full text blocked or not read; no supplement appraisal claimed.

  8. 8
    AAO 2022: NAION diagnosis and management

    Selected indexed official source sections read on 2026-11-09; direct full text blocked or not read; no supplement appraisal claimed.

  9. 9
    ONTT 1992

    Indexed treatment-assignment and visual-outcome/recurrence results read; trial manual, full long-term reports and supplements unread.

  10. 10
    Morrow et al 2018: bioequivalent oral versus IV trial

    Complete indexed abstract read; full report and supplements not read.

  11. 11
    Mollan et al 2018: IIH consensus guidelines

    Selected indexed official source sections read on 2026-11-09; direct full text blocked or not read; no supplement appraisal claimed.

Original lecture link